• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. CRYOFLEX SURGICAL ABLATION PROBE; SURGICAL DEVICE, FOR ABLATION OF CARDIAC TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. CRYOFLEX SURGICAL ABLATION PROBE; SURGICAL DEVICE, FOR ABLATION OF CARDIAC TISSUE Back to Search Results
Model Number 60SF2
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular Dissection (3160)
Event Date 09/01/2012
Event Type  Death  
Manufacturer Narrative
Date of death: the exact date of death was not reported in the article (the patient developed multiorgan failure and died on postoperative day 5).Literature article: aortic dissection type a after right atrial cryoablation during port access mitral valve surgery doi:10.1097/imi.0b013e3182744646.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a case where a (b)(6)-year-old woman underwent minimal invasive mitral and tricuspid valve repair and a concomitant cryomaze procedure.All data was collected from a single center.A medtronic cryoflex probe was used to perform the concomitant cryomaze procedure (serial or model numbers not provided).During the minimally invasive procedure the cryoflex probe was used to successfully carry out left atrial cryomaze.Each lesion was created for 2 minutes,with a target temperature of -150 c.Thereafter, the mitral valve was reconstructed with a 28-mm rigid anuloplasty ring.Subsequently, a right-sided cryomaze was performed, with lines elongating the atrial incision into the superior caval vein, then from the lateral wall of the right atrium toward the tricuspid valve annulus, and then a line from the annulus of the anterior tricuspid leaflet toward then right atrial appendage.While performing this last line a fall in blood pressure was noted, that was accompanied by a drop in electrical cerebral activity, and a rise in central venous pressure.After administration of neosynephrine, hemodynamics normalized again.In the meantime,the aortic clamp was released to perform the tricuspid valve reconstruction on the beating heart.At the same time, blood pressure, monitored in the right radial artery, disappeared, whereas it remained normal in the left radial artery.An investigation was conduced by transesophageal echocardiography and this revealed an intimal flap in the ascending aorta indicative of acute aortic dissection.Concomitantly, a bleeding from the aortic annulus was detected, the exact localization could not be defined through the minimal invasive incision, so an emergency sternotomy was performed, and the patient cooled down to 18 c.After reaching 18 c body temperature, deep hypothermic circulatory arrest was established with retrograde cerebral perfusion and the aorta was opened.The aortic wall was free of atherosclerosis, and no entry was detected in the ascending aorta and aortic arch.The ascending aorta was replaced with a 28-mm prosthesis.It was noted that the dissection also involved the right coronary sinus and the right coronary ostium, with complete detachment of the right coronary artery (rca) 1 cm distal of the origin of the artery which was also the source of the bleeding.A venous aortocoronary bypass grafting to the proximal rca was subsequently performed, and the right ostium was oversewn.The patient could not be weaned from cardio pulmonary bypass (cpb) because of respiratory compromise and a massive vascular leak caused by the long pump run (extra corporeal circulation, 545 minutes; aortic cross-clamp time, 212 minutes).Therefore, a central extracorporeal membrane oxygenation (ecmo) device was installed, and the patient was switched from cpb to the ecmo.The patient developed multiorgan failure and died on postoperative day 5.At postmortem, a dissection caused by cannulation of the right femoral artery could be ruled out because the dissection ended at the left iliac artery.Based on the available information the dissection may have been associated with the medtronic product.Based on the available information the death was not attributed to the medtronic product.No device malfunctions were mentioned in the article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRYOFLEX SURGICAL ABLATION PROBE
Type of Device
SURGICAL DEVICE, FOR ABLATION OF CARDIAC TISSUE
Manufacturer (Section D)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer (Section G)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key10275111
MDR Text Key198841964
Report Number3008592544-2020-00038
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K123733
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other
Type of Report Initial
Report Date 07/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number60SF2
Device Catalogue Number60SF2
Was Device Available for Evaluation? No
Date Manufacturer Received06/20/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age63 YR
-
-